Manohar et al investigate the cost of utilizing bone-modifying agents in the treatment of patients with metastatic cancer and bone involvement at a National Cancer Institute–designated cancer center.
Manohar et al investigate the cost of utilizing bone-modifying agents in the treatment of patients with metastatic cancer and bone involvement at a National Cancer Institute–designated cancer center.
Currently, there are two main commercially available closed incision negative pressure therapy (ciNPT) systems: one using a foam dressing (FOAM*) and another with a multilayer absorbent (...